BIOSITE INC 4
4 · BIOSITE INC · Filed Jun 29, 2007
Insider Transaction Report
Form 4
BIOSITE INCBSTE
HIBBERD CHRISTOPHER R
SVP Bus Dvlpmnt & Strat Plan
Transactions
- Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−1,873→ 0 totalExercise: $53.38Exp: 2015-06-17→ Common Stock (1,873 underlying) - Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−255→ 0 totalExercise: $49.15Exp: 2014-10-22→ Common Stock (255 underlying) - Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−1,979→ 0 totalExercise: $44.18Exp: 2014-06-18→ Common Stock (1,979 underlying) - Disposition from Tender
Common Stock
2007-06-29$92.50/sh−404$37,370→ 0 total - Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−2,000→ 0 totalExercise: $13.88Exp: 2008-05-21→ Common Stock (2,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−2,280→ 0 totalExercise: $44.18Exp: 2014-06-18→ Common Stock (2,280 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−3,495→ 0 totalExercise: $49.15Exp: 2014-10-22→ Common Stock (3,495 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−15,627→ 0 totalExercise: $53.38Exp: 2015-06-17→ Common Stock (15,627 underlying)
Footnotes (7)
- [F1]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 3,583 shares of Inverness common stock for $7.75 per share.
- [F2]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 3,545 shares of Inverness common stock for $24.66 per share.
- [F3]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 456 shares of Inverness common stock for $27.44 per share.
- [F4]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 3,355 shares of Inverness common stock for $29.80 per share.
- [F5]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 4,084 shares of Inverness common stock for $24.66 per share.
- [F6]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 6,261 shares of Inverness common stock for $27.44 per share.
- [F7]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 27,997 shares of Inverness common stock for $29.80 per share.